Primary Job Title Dizney Eminent Scholar and Distinguished Professor Primary Organization 
University of Florida
Gender Male
Dr. Gold has combined academic achievement with business and management expertise in a successful career in medicine, academics and finance. He is currently serving as Dizney Eminent Scholar and Distinguished Professor at the University of Florida College of Medicine's Brain Institute in the Departments of Psychiatry, Neuroscience,
Anesthesiology, Community Health & Family Medicine, where he is also Interim Chair and Chief in the Division of Addiction Medicine.
Over his 35 year translational research career, Dr. Gold has done extensive laboratory and clinical research with drugs of abuse, medications, adherence and monitoring. In the field of medical technology, he is a co-inventor of technology for testing of medication Dr. Gold and his Yale colleagues pioneered and automated cocaine testing in blood and urine as well as for other drugs of abuse. adherence and compliance, and therapeutic drug monitoring for medication used to treat epilepsy and other medical conditions. Dr Gold has had considerable experience and success in developing laboratory models for addictions and then developing new treatments. He is one of a very few researchers to have patented important new uses for existing medications without a university as a co-inventor or owner of the patent, and to have then sold the patent to a major multinational pharmaceutical company for manufacture and marketing.
Dr. Gold combines his medical knowledge with many years of experience in business and finance, where he has consulted for companies such as Medtronic, Ciba-Geigy, Merck, Wyeth, Roche, Alkermes, Dupont, Glaxo, Abbott, and Forest Laboratories. He was a major investor and founding member for Aklaim Video, the company responsible for the leading video game Mortal Kombat. He was a co-founder and founding director of Somerset Valley Bank, helping the bank go from concept to its first bank opening, to a chain, to its public listing on NASDAQ and to its sale for nearly $100 million. Dr. Gold has provided consulting services to top-tier financial firms such as Goldman Sachs, Lehman Brothers, Oppenheimer, the Carlyle Group and Smith Barney, as well as currently co-authoring a subscription financial newsletter for Phillips.
As a world-renowned addiction researcher, Dr. Gold has been involved in the development of numerous new approaches which have rapidly progressed from bench-to-bedside. His research has led to changes in the treatment of physician addiction, opiate and cocaine addiction and food addiction. He is the author of twelve professional books and over 900 medical articles, chapters, and abstracts in journals for health professionals. He is frequently the expert interviewed for comment by the Wall Street Journal ,other major business, and national publications concerned with the strengths and limitations of new technology and treatments in obesity, pain, drug addiction and psychiatry.
